SYNERGEN’s SENSATIONAL SURGE SIGNIFIES "STREET" APPEAL OF LONG-TERM PROSPECTS; BIOTECH BOOM BRINGS WIDE GROUP BACK; 17 ISSUES GAIN MORE THAN 50%

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".